National trends in outcomes of ischemic stroke and prognostic influence of stroke center capability in Japan, 2010-2016.

Ischemic stroke in-hospital mortality stroke center

Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
25 Oct 2019
Historique:
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 28 10 2019
Statut: aheadofprint

Résumé

Limited national-level information on temporal trends in comprehensive stroke center capabilities and their effects on acute ischemic stroke patients exists. To examine trends in in-hospital outcomes of acute ischemic stroke patients and the prognostic influence of temporal changes in comprehensive stroke center capabilities in Japan. This retrospective study used the J-ASPECT Diagnosis Procedure Combination database and identified 372,978 acute ischemic stroke patients hospitalized in 650 institutions between 2010 and 2016. Temporal trends in patient outcomes and recombinant tissue plasminogen activator (rt-PA) and mechanical thrombectomy usage were examined. Facility comprehensive stroke center capabilities were assessed using a validated scoring system (comprehensive stroke center score: 1-25 points) in 2010 and 2014. The prognostic influence of temporal comprehensive stroke center score changes on in-hospital mortality and poor outcomes (modified Rankin Scale: 3-6) at discharge were examined using hierarchical logistic regression models. Over time, stroke severity at admission decreased, whereas median age, sex ratio, and comorbidities remained stable. The median comprehensive stroke center score increased from 16 to 17 points. After adjusting for age, sex, comorbidities, consciousness level, and facility comprehensive stroke center score, proportion of in-hospital mortality and poor outcomes at discharge decreased (from 7.6% to 5.0%, and from 48.7% to 43.1%, respectively). The preceding comprehensive stroke center score increase (in 2010-2014) was independently associated with reduced in-hospital mortality and poor outcomes, and increased rt-PA and mechanical thrombectomy use (odds ratio (95% confidence interval): 0.97 (0.95-0.99), 0.97 (0.95-0.998), 1.07 (1.04-1.10), and 1.21 (1.14-1.28), respectively). This nationwide study revealed six-year trends in better patient outcomes and increased use of rt-PA and mechanical thrombectomy in acute ischemic stroke. In addition to lesser stroke severity, preceding improvement of comprehensive stroke center capabilities was an independent factor associated with such trends, suggesting importance of comprehensive stroke center capabilities as a prognostic indicator of acute stroke care.

Sections du résumé

BACKGROUND BACKGROUND
Limited national-level information on temporal trends in comprehensive stroke center capabilities and their effects on acute ischemic stroke patients exists.
AIMS OBJECTIVE
To examine trends in in-hospital outcomes of acute ischemic stroke patients and the prognostic influence of temporal changes in comprehensive stroke center capabilities in Japan.
METHODS METHODS
This retrospective study used the J-ASPECT Diagnosis Procedure Combination database and identified 372,978 acute ischemic stroke patients hospitalized in 650 institutions between 2010 and 2016. Temporal trends in patient outcomes and recombinant tissue plasminogen activator (rt-PA) and mechanical thrombectomy usage were examined. Facility comprehensive stroke center capabilities were assessed using a validated scoring system (comprehensive stroke center score: 1-25 points) in 2010 and 2014. The prognostic influence of temporal comprehensive stroke center score changes on in-hospital mortality and poor outcomes (modified Rankin Scale: 3-6) at discharge were examined using hierarchical logistic regression models.
RESULTS RESULTS
Over time, stroke severity at admission decreased, whereas median age, sex ratio, and comorbidities remained stable. The median comprehensive stroke center score increased from 16 to 17 points. After adjusting for age, sex, comorbidities, consciousness level, and facility comprehensive stroke center score, proportion of in-hospital mortality and poor outcomes at discharge decreased (from 7.6% to 5.0%, and from 48.7% to 43.1%, respectively). The preceding comprehensive stroke center score increase (in 2010-2014) was independently associated with reduced in-hospital mortality and poor outcomes, and increased rt-PA and mechanical thrombectomy use (odds ratio (95% confidence interval): 0.97 (0.95-0.99), 0.97 (0.95-0.998), 1.07 (1.04-1.10), and 1.21 (1.14-1.28), respectively).
CONCLUSIONS CONCLUSIONS
This nationwide study revealed six-year trends in better patient outcomes and increased use of rt-PA and mechanical thrombectomy in acute ischemic stroke. In addition to lesser stroke severity, preceding improvement of comprehensive stroke center capabilities was an independent factor associated with such trends, suggesting importance of comprehensive stroke center capabilities as a prognostic indicator of acute stroke care.

Identifiants

pubmed: 31653178
doi: 10.1177/1747493019884526
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1747493019884526

Auteurs

Akiko Kada (A)

Department of Clinical Research Management, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

Kuniaki Ogasawara (K)

Department of Neurosurgery, Iwate Medical University, Morioka, Japan.

Takanari Kitazono (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan.

Nobuyuki Sakai (N)

Department of Neurosurgery, Kobe City General Hospital, Kobe, Japan.

Daisuke Onozuka (D)

Department of Health Communication, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yoshiaki Shiokawa (Y)

Department of Neurosurgery, Kyorin University, Mitaka, Japan.

Shigeru Miyachi (S)

Department of Neurosurgery, Neuroendovascular Therapy Center, Aichi Medical University, Nagakute, Japan.

Izumi Nagata (I)

Department of Neurosurgery, Kokura Memorial Hospital, Kita-Kyushu, Japan.

Kazunori Toyoda (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Yoichiro Hashimoto (Y)

Department of Neurology, Kumamoto City Hospital, Kumamoto, Japan.

Yasuhiro Hasegawa (Y)

Department of Neurology, St. Marianna University School of Medicine, Kawasaki, Japan.

Haruhiko Hoshino (H)

Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.

Shinichi Yoshimura (S)

Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan.

Michiyasu Suzuki (M)

Department of Neurosurgery, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Akira Tsujino (A)

Department of Neurology and Strokology, Nagasaki University Hospital, Nagasaki, Japan.

Shinya Matsuda (S)

Department of Preventive Medicine and Community Health, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Japan.

Ryota Kurogi (R)

Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Ai Kurogi (A)

Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Nice Ren (N)

Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Ataru Nishimura (A)

Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Koichi Arimura (K)

Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Akihito Hagihara (A)

Department of Health Communication, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Teiji Tominaga (T)

Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.

Takamasa Kayama (T)

Department of Advanced Medicine, Yamagata University School of Medicine, Yamagata, Japan.

Hajime Arai (H)

Department of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan.

Norihiro Suzuki (N)

Department of Neurology, Shonan Keiiku Hospital, Fujisawa, Japan.

Susumu Miyamoto (S)

Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Akira Ogawa (A)

Department of Neurosurgery, Iwate Medical University, Morioka, Japan.

Koji Iihara (K)

Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Classifications MeSH